Central Pharmaceutical Joint Stock Company No3 reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 124,625.53 million compared to VND 95,300.15 million a year ago. Net income was VND 29,631.64 million compared to VND 30,994.98 million a year ago. Basic earnings per share from continuing operations was VND 3,446 compared to VND 3,604 a year ago.
For the six months, revenue was VND 251,328.04 million compared to VND 192,973.23 million a year ago. Net income was VND 51,788.83 million compared to VND 48,876.38 million a year ago. Basic earnings per share from continuing operations was VND 6,022 compared to VND 5,683 a year ago.